Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The company also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its model services also include syngeneic mouse tumor allograft and select human cell line derived xenograft (CDX) models, and it offers GLP-compliant preclinical testing services in various small animal models. The company provides its services to the federal government, universities and the life science and pharmaceutical industries.
Follow-Up Questions
¿Cuál es el ratio P/E de Bioqual Inc (BIOQ)?
El ratio P/E de Bioqual Inc es 41.7206
¿Quién es el CEO de Bioqual Inc?
Mr. Mark Lewis es el Chairman of the Board de Bioqual Inc, se unió a la empresa desde 2015.
¿Qué tal es el rendimiento del precio de la acción BIOQ?
El precio actual de BIOQ es de $39, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Bioqual Inc?
Bioqual Inc pertenece a la industria Biotechnology y el sector es Health Care
¿Cuál es la capitalización bursátil de Bioqual Inc?
La capitalización bursátil actual de Bioqual Inc es $34.7M
